Patent · US Active

Extended release venlafaxine besylate tablets

US7776358B2 · kind B2 · utility

0Cited by
14References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2004
Grant dateAug 17, 2010
Priority date—
Expiry dateMay 16, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2846
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Venlafaxine besylate is formulated into an extended release tablet in high loading rates by use of a coating that contains ammonio methacrylate copolymer(s).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.